Activation of Sickle Red Cell Adhesion

镰状红细胞粘附的激活

基本信息

  • 批准号:
    6899320
  • 负责人:
  • 金额:
    $ 11.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2007-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The vaso-occlusive process in patients with sickle cell disease (SCD) is complex and involves interactions both between hemoglobin S red blood cells (SS RBC) and vascular endothelium, and between SS RBC and leukocytes adherent to endothelium. Vaso-occlusive events lead to recurrent pain and cerebrovascular accidents in both children and adults, as well as other types of end-organ damage, including pulmonary hypertension and renal failure. However, the physiologic triggers inducing SS RBC adhesion and vaso-occlusion are poorly understood, and elucidation of these mechanisms at the molecular level would allow development of new preventive and treatment strategies to abrogate vaso-occlusive events. We have begun to explore the role of SS RBC cAMP signal transduction pathways in upregulating SS RBC adhesion to endothelial cells (EC). We have found that treatment of SS RBC with agents such as epinephrine, that lead to elevation of intracellular cAMP, induced enhanced SS RBC adhesion to EC and that this signaling pathway is also dependent on tyrosine phosphorylation. We have also shown that interaction between SS RBC and EC is mediated at least primarily by the adhesion receptor LW (ICAM-4) on SS RBC, which binds to alphav-beta3 integrin on EC. LW also binds to leukocyte integrins. We therefore hypothesize that abnormal circulating SS RBC adhesion to endothelium and to adherent leukocytes may at least in part be due to SS RBC adhesion receptor activation in vivo by processes involving upregulation of endogenous cAMP, leading to activation of LW adhesion receptor on SS RBC. We propose therefore to explore the molecular basis of SS RBC adhesion to both endothelium and leukocytes. Our specific aims are 1) to characterize the effects of physiologic adrenergic agonists known to lead to increased cAMP on LW-mediated SS RBC adhesion to endothelial cells both in vitro and ex vivo; 2) to characterize the mechanism of activation of the LW receptor; and 3) to investigate the possible role of LW in the interaction of SS RBC with leukocytes. Overall, these experiments will elucidate the molecular mechanisms of LW-mediated SS RBC adhesion to endothelium and leukocytes, and thus how physiologic stress and stress hormones may contribute to vaso-occlusion.
描述(由申请人提供): 镰状细胞病(SCD)患者的血管闭塞过程是复杂的,涉及血红蛋白S红细胞(SS RBC)和血管内皮之间的相互作用,以及SS RBC和粘附于内皮的白细胞之间的相互作用。血管闭塞事件导致儿童和成人的复发性疼痛和脑血管意外,以及其他类型的终末器官损伤,包括肺动脉高压和肾衰竭。然而,诱导SS RBC粘附和血管闭塞的生理触发因素知之甚少,在分子水平上阐明这些机制将允许开发新的预防和治疗策略以消除血管闭塞事件。我们已经开始探索SS RBC cAMP信号转导通路在上调SS RBC与内皮细胞(EC)粘附中的作用。我们已经发现,用诸如肾上腺素的药剂处理SS RBC,导致细胞内cAMP升高,诱导增强的SS RBC粘附于EC,并且该信号传导途径也依赖于酪氨酸磷酸化。我们还表明SS RBC和EC之间的相互作用至少主要由SS RBC上的粘附受体LW(ICAM-4)介导,其结合EC上的α v-β 3整联蛋白。LW还结合白细胞整联蛋白。因此,我们推测,异常循环SS RBC粘附内皮细胞和粘附的白细胞可能至少部分是由于SS RBC粘附受体在体内激活的过程中,涉及内源性cAMP的上调,导致激活的LW粘附受体SS RBC。因此,我们建议探讨SS红细胞粘附内皮细胞和白细胞的分子基础。我们的具体目标是:1)表征已知导致cAMP增加的生理性肾上腺素能激动剂对体外和离体LW介导的SS RBC与内皮细胞粘附的影响; 2)表征LW受体活化的机制; 3)研究LW在SS RBC与白细胞相互作用中的可能作用。总的来说,这些实验将阐明LW介导的SS RBC粘附到内皮细胞和白细胞的分子机制,以及生理应激和应激激素如何导致血管闭塞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rahima Zennadi其他文献

Rahima Zennadi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rahima Zennadi', 18)}}的其他基金

Oxidative stress mechanisms regulating gamma-globin gene transcription in sickle cell disease
镰状细胞病中调节伽马珠蛋白基因转录的氧化应激机制
  • 批准号:
    10649412
  • 财政年份:
    2022
  • 资助金额:
    $ 11.72万
  • 项目类别:
Oxidative stress mechanisms regulating gamma-globin gene transcription in sickle cell disease
镰状细胞病中调节伽马珠蛋白基因转录的氧化应激机制
  • 批准号:
    10340421
  • 财政年份:
    2022
  • 资助金额:
    $ 11.72万
  • 项目类别:
The Role of RBC Reactive Oxygen Species in Regulating Thrombotic Events During Aging
红细胞活性氧在调节衰老过程中血栓事件中的作用
  • 批准号:
    10293939
  • 财政年份:
    2021
  • 资助金额:
    $ 11.72万
  • 项目类别:
The Role of RBC Reactive Oxygen Species in Regulating Thrombotic Events During Aging
红细胞活性氧在调节衰老过程中血栓事件中的作用
  • 批准号:
    10622574
  • 财政年份:
    2021
  • 资助金额:
    $ 11.72万
  • 项目类别:
The Role of RBC Reactive Oxygen Species in Regulating Thrombotic Events During Aging
红细胞活性氧在调节衰老过程中血栓事件中的作用
  • 批准号:
    10461852
  • 财政年份:
    2021
  • 资助金额:
    $ 11.72万
  • 项目类别:
Activation of Sickle Red Cell Adhesion
镰状红细胞粘附的激活
  • 批准号:
    6676784
  • 财政年份:
    2003
  • 资助金额:
    $ 11.72万
  • 项目类别:
Activation of Sickle Red Cell Adhesion
镰状红细胞粘附的激活
  • 批准号:
    6793200
  • 财政年份:
    2003
  • 资助金额:
    $ 11.72万
  • 项目类别:
Activation of Sickle Red Cell Adhesion
镰状红细胞粘附的激活
  • 批准号:
    7070077
  • 财政年份:
    2003
  • 资助金额:
    $ 11.72万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.72万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 11.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了